|
|
xi | |
|
|
xiii | |
|
|
xv | |
Foreword |
|
xvii | |
Acknowledgements |
|
xix | |
|
1 Social and political background |
|
|
1 | (17) |
|
|
|
1 | (3) |
|
National and international models of support for management of LTCs |
|
|
4 | (4) |
|
|
8 | (1) |
|
Policy drivers United Kingdom |
|
|
9 | (8) |
|
Further areas to consider |
|
|
17 | (1) |
|
2 Physical, psychological and psychosocial impact of living with a long-term condition and social influences on health |
|
|
18 | (17) |
|
|
|
18 | (1) |
|
|
19 | (10) |
|
Psychologicallpsychosocial impact |
|
|
29 | (1) |
|
Social influences on health |
|
|
30 | (4) |
|
|
34 | (1) |
|
Further areas to consider |
|
|
34 | (1) |
|
3 Care coordination and the role of multi-disciplinary teams |
|
|
35 | (15) |
|
|
|
|
|
35 | (1) |
|
Case management/care coordination |
|
|
36 | (2) |
|
Disease-specific care management |
|
|
38 | (1) |
|
Role of the district nurse in the management ofpeople with LTCs |
|
|
39 | (2) |
|
Role of the general practice nurse in the management of people with LTCs |
|
|
41 | (4) |
|
Roles and responsibilities |
|
|
45 | (1) |
|
Role of the multi-disciplinary team in the management ofpeople with LTCs |
|
|
46 | (2) |
|
|
48 | (1) |
|
|
49 | (1) |
|
Further areas to consider |
|
|
49 | (1) |
|
4 Importance of self-management |
|
|
50 | (13) |
|
|
Introduction and definition |
|
|
50 | (2) |
|
Evidence supporting self-management interventions |
|
|
52 | (1) |
|
Components of supported self-management |
|
|
53 | (3) |
|
|
56 | (1) |
|
Who's suitable for self-care? |
|
|
57 | (1) |
|
Self-management programmes |
|
|
58 | (2) |
|
|
60 | (1) |
|
Further areas to consider |
|
|
60 | (1) |
|
Organisations that advise on self-management |
|
|
60 | (3) |
|
5 Behaviour change strategies |
|
|
63 | (21) |
|
|
Behaviour change within primary care |
|
|
63 | (1) |
|
|
63 | (1) |
|
|
64 | (2) |
|
Reflective exercise guidance |
|
|
66 | (1) |
|
Mind the gap! Knowledge and behaviour |
|
|
67 | (1) |
|
Theoretical contributions to understanding behaviour change |
|
|
68 | (1) |
|
Behaviour change guidance and initiatives |
|
|
69 | (2) |
|
|
71 | (1) |
|
Motivational interviewing |
|
|
72 | (7) |
|
Planning and goal setting |
|
|
79 | (3) |
|
Developing proficiency in Motivational Interviewing |
|
|
82 | (1) |
|
|
83 | (1) |
|
6 How to identify a person with a long-term condition |
|
|
84 | (16) |
|
|
|
84 | (1) |
|
|
85 | (9) |
|
|
94 | (2) |
|
Musculoskeletal conditions |
|
|
96 | (3) |
|
|
99 | (1) |
|
|
99 | (1) |
|
Further areas to consider |
|
|
99 | (1) |
|
7 Effective management of people with a long-term condition |
|
|
100 | (18) |
|
|
|
100 | (1) |
|
|
101 | (2) |
|
The 3 Rs- registrationlrecalllreview |
|
|
103 | (7) |
|
Teamwork and referral criteria |
|
|
110 | (1) |
|
Quality improvement and audit |
|
|
110 | (2) |
|
Digital health interventions |
|
|
112 | (2) |
|
Rehabilitation and palliative (end of life) care |
|
|
114 | (2) |
|
|
116 | (1) |
|
|
117 | (1) |
|
Further areas to consider |
|
|
117 | (1) |
|
8 Evidence-based healthcare |
|
|
118 | (16) |
|
|
|
|
118 | (1) |
|
Definitions and brief history of evidence-based healthcare (EBHC) |
|
|
119 | (2) |
|
Applying evidence to practice |
|
|
121 | (7) |
|
Evidence implementation!quality improvement |
|
|
128 | (1) |
|
|
128 | (2) |
|
So how can you improve quality in healthcare? |
|
|
130 | (1) |
|
Quality improvement approaches |
|
|
130 | (1) |
|
|
131 | (1) |
|
|
132 | (1) |
|
|
133 | (1) |
|
|
133 | (1) |
|
Further areas to consider |
|
|
133 | (1) |
|
|
134 | (30) |
|
|
|
134 | (1) |
|
Part One Respiratory conditions |
|
|
135 | (7) |
|
|
142 | (3) |
|
Musculoskeletal conditions |
|
|
145 | (3) |
|
|
148 | (1) |
|
Part Two People with more complex needs |
|
|
149 | (7) |
|
|
156 | (6) |
|
|
162 | (1) |
|
|
163 | (1) |
|
Further areas to consider |
|
|
163 | (1) |
|
10 Nutritional and medication management |
|
|
164 | (18) |
|
|
|
|
164 | (1) |
|
Part One Nutritional management of patients with LTCs |
|
|
164 | (7) |
|
|
171 | (4) |
|
|
175 | (1) |
|
|
175 | (1) |
|
Further areas to consider |
|
|
176 | (1) |
|
Part Two Medicines management/medicines optimisation |
|
|
176 | (3) |
|
Non-medical prescribing and its impact on LTC management |
|
|
179 | (2) |
|
|
181 | (1) |
|
|
181 | (1) |
|
Further areas to consider |
|
|
181 | (1) |
|
|
182 | (2) |
|
References |
|
184 | (19) |
Index |
|
203 | |